HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q2 2021

SEC EDGAR SourceSEC Filings

Top Holdings89 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ONCONC
ADR

BEIGENE LTD-ADR

5.5M$1.9B19.3%$134.02+166.43%
11 qtrssince 2018-Q4
Unchanged
0
PDDPDD
ADR

PDD HOLDINGS INC

6.9M$876.7M9.0%$34.04+292.28%
11 qtrssince 2018-Q4
Decreased
0
IQIQ
ADR

IQIYI INC

38.6M$602.1M6.2%$18.39-14.42%
11 qtrssince 2018-Q4
Unchanged
0
NBPNBP
ADR

NOVABRIDGE BIOSCIENCES

6.6M$555.4M5.7%$45.18+78.83%
4 qtrssince 2020-Q3
Unchanged
0
ESGRESGRDelisted

ENSTAR GROUP LIMITED

1.7M$417.6M4.3%
10 qtrssince 2019-Q1
Unchanged
0

ZOOM COMMUNICATIONS INC

1M$397.6M4.1%$84.35+367.95%
7 qtrssince 2019-Q4
Decreased
0

BRIDGEBIO PHARMA INC

5.4M$326.9M3.4%$28.25+112.78%
9 qtrssince 2019-Q2
Unchanged
0

AIRBNB INC-CLASS A

2.1M$323.5M3.3%$146.080.00%
1 qtr
New
86
JDJD
ADR

JD.COM INC-ADR

3.7M$294M3.0%$44.76+61.68%
11 qtrssince 2018-Q4
Decreased
0

SALESFORCE.COM INC

1.1M$277.6M2.9%$184.99+31.29%
6 qtrssince 2020-Q1
Unchanged
0

UBER TECHNOLOGIES INC

5.4M$271.7M2.8%$29.72+70.80%
8 qtrssince 2019-Q3
Decreased
0
BILIBILI
ADR

BILIBILI INC-SPONSORED ADR

2M$243.5M2.5%$15.50+710.24%
11 qtrssince 2018-Q4
Unchanged
0
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

5M$239M2.5%$62.02-26.57%
4 qtrssince 2020-Q3
Unchanged
0

BEAM THERAPEUTICS INC

1.8M$237.6M2.4%$18.00+515.50%
6 qtrssince 2020-Q1
Decreased
0

DOORDASH INC - A

1.2M$213.3M2.2%$141.95+29.56%
3 qtrssince 2020-Q4
Increased
57
APLSAPLSDelisted

APELLIS PHARMACEUTICALS INC

2.9M$185.2M1.9%$19.43
11 qtrssince 2018-Q4
Decreased
0
VIPSVIPS
ADR

VIPSHOP HLDGS LTD

9M$180M1.9%$19.34-2.78%
2 qtrssince 2021-Q1
Increased
77
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

713,400$161.8M1.7%$213.400.00%
2 qtrssince 2021-Q1
Increased
77
MNSOMNSO
ADR

MINISO GROUP HLDG LTD

5.7M$117.5M1.2%$18.68-1.51%
3 qtrssince 2020-Q4
Increased
76

MONDELEZ INTERNATIONAL INC-A

1.9M$116.3M1.2%$33.70+64.81%
11 qtrssince 2018-Q4
Unchanged
0
$9.7B
AUM
89
Positions
Q2 2021
Filing
Rating · 2.0
Quarterly Portfolio Change
-8%Q1'20$7.4B+47%Q2'20$10.9B+21%Q3'20$13.2B-5%Q4'20$12.6B-20%Q1'21$10.1B-4%Q2'21$9.7B
Activity profile
$ moved · Q2'21
New19%Increased19%Decreased46%Exited15%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.3 years
<1Q9%1-4Q29%1-2Y27%2Y+35%

HHLR ADVISORS, LTD. manages $9.7B across 89 positions as of Q2 2021. Top holdings: ONC (19.3%), PDD (9.0%), IQ (6.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q2 2021 Summary

Active quarter - 9 new positions, 11 exits, 6 increased. Top move: ABNB (NEW, conviction 86). Portfolio: $9.7B across 89 positions.

Top holdings by portfolio weight

Total AUM$10B
ONC19.33%
PDD9.02%
IQ6.20%
NBP5.72%
ESGR4.30%
ZM4.09%
BBIO3.36%
ABNB3.33%
JD3.03%
CRM2.86%
Other2.80%

Portfolio allocation by GICS sector

Sectors9
Healthcare40.66%
Consumer Cyclical24.32%
Technology12.33%
Communication Services10.18%
Unknown6.42%
Real Estate2.46%
Consumer Defensive1.43%
Industrials1.33%
Financial Services0.88%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Consumer Cyclical, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction42
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used